Education
About Us
Working with TipRanks
Follow Us
cbdMD (YCBD)
:YCBD
YCBD Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.59 - $6.54
Previous CloseN/A
Volume938.08K
Average Volume (3M)106.54K
Market Cap
$6.33M
Enterprise Value$5.06M
Total Cash (Recent Filing)$1.06M
Total Debt (Recent Filing)$962.74K
Price to Earnings (P/E)―
Beta0.12
Next Earnings
Dec 23, 2025EPS Estimate
-0.07Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.21
Shares Outstanding8,912,959
10 Day Avg. Volume150,891
30 Day Avg. Volume106,537
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap0.80
Enterprise Value/Revenue0.27
Enterprise Value/Gross Profit0.43
Enterprise Value/Ebitda-25.18
Forecast
1Y Price Target
$1.50Price Target Upside114.29% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Bulls Say, Bears Say
Bulls Say
Financial FlexibilityThe successful conversion of Series A preferred stock into common equity is seen as a significant milestone, enhancing financial flexibility by eliminating all accrued and future dividend obligations.
Marketing And Product MomentumThe company has improved marketing execution, a cleaner capital structure, and growing momentum across its diversified product portfolio, positioning it to return to sales growth and maintain its listing status.
Product ExpansionHerbal Oasis, YCBD's hemp-derived THC beverage brand, recently expanded distribution into Tennessee and Minnesota, with product availability in these markets expected in September.
Bears Say
Financial Estimates And Stock TargetDue to lower estimates and significant dilution related to the company's automatic preferred-to-common equity conversion, the price target is reduced to $3.00 from $16.00.
Growth LimitationsWe expect regulatory headwinds to persist, limiting growth through 2026.
Retail Demand And Regulatory ChallengesF3Q25 results missed expectations, reflecting ongoing softness in retail demand for CBD products, further pressured by state-level regulatory changes and proposals that have heightened uncertainty across the broader cannabinoid retail market and weighed on wholesale performance.
cbdMD News
YCBD FAQ
What was cbdMD’s price range in the past 12 months?
cbdMD lowest stock price was $0.59 and its highest was $6.54 in the past 12 months.
What is cbdMD’s market cap?
cbdMD’s market cap is $6.33M.
When is cbdMD’s upcoming earnings report date?
cbdMD’s upcoming earnings report date is Dec 23, 2025 which is in 116 days.
How were cbdMD’s earnings last quarter?
cbdMD released its earnings results on Aug 14, 2025. The company reported -$0.21 earnings per share for the quarter, missing the consensus estimate of -$0.02 by -$0.19.
Is cbdMD overvalued?
According to Wall Street analysts cbdMD’s price is currently Undervalued.
Does cbdMD pay dividends?
cbdMD does not currently pay dividends.
What is cbdMD’s EPS estimate?
cbdMD’s EPS estimate is -0.07.
How many shares outstanding does cbdMD have?
cbdMD has 8,912,959 shares outstanding.
What happened to cbdMD’s price movement after its last earnings report?
cbdMD reported an EPS of -$0.21 in its last earnings report, missing expectations of -$0.02. Following the earnings report the stock price went down -10.588%.
Which hedge fund is a major shareholder of cbdMD?
Currently, no hedge funds are holding shares in YCBD
Company Description
cbdMD
cbdMD, Inc. produces and distributes various cannabidiol (CBD) products. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, bath bombs, bath salts, and sleep aids. It also offers veterinarian-formulated products, including tinctures, chews, and topicals under the Paw CBD brand name. The company distributes its products through its e-commerce Website, third-party e-commerce sites, wholesalers, and various brick and mortar retailers in the United States. It has a research partnership with the University of Mississippi to identify novel cannabinoids. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. was incorporated in 2015 and is headquartered in Charlotte, North Carolina.
YCBD Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted successful capital restructuring and cost reductions, along with growth in wholesale revenue and an award-winning product launch. However, challenges include a decrease in total net sales, flat e-commerce revenue, and a negative working capital position.View all YCBD earnings summariesYCBD Stock 12 Month Forecast
Average Price Target
$1.50
▲(114.29% Upside)
Technical Analysis
Tilray
―
Takeda Pharmaceutical Company
―
SNDL
―
Flora Growth
―
Shuttle Pharmaceuticals Holdings, Inc.
―
Ownership Overview
7.80% Insiders
0.01% Mutual Funds
3.92% Other Institutional Investors
87.96% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---